regeneron_defa14a.htm
SCHEDULE 14A
 
(Rule 14a-101)
 
INFORMATION REQUIRED IN PROXY STATEMENT
 
SCHEDULE 14A INFORMATION
 
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
 
Filed by the Registrant [x]
Filed by a Party other than the Registrant [_]

Check the appropriate box:
[_]  Preliminary Proxy Statement                  [_] Soliciting Material Under Rule
[_]  Confidential, For Use of the                        14a-12
       Commission Only (as permitted
       by Rule 14a-6(e)(2))
[_]  Definitive Proxy Statement
[x]  Definitive Additional Materials
 
Regeneron Pharmaceuticals, Inc
------------------------------------------------------------------------------------------------------------------------------------------------------
 
(Name of Registrant as Specified In Its Charter)
 
------------------------------------------------------------------------------------------------------------------------------------------------------
 
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
[x]  No fee required.
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
 
1)  Title of each class of securities to which transaction applies:
____________________________________________________________________________________
2)  Aggregate number of securities to which transaction applies:
3)  Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the
     amount on which the filing fee is calculated and state how it was determined):
4)  Proposed maximum aggregate value of transaction:
____________________________________________________________________________________
5)  Total fee paid:
[_] Fee paid previously with preliminary materials:
[_] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which
      the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or
      schedule and the date of its filing.
____________________________________________________________________________________
      1) Amount previously paid:
____________________________________________________________________________________
      2) Form, Schedule or Registration Statement No.:
____________________________________________________________________________________
      3) Filing Party:
____________________________________________________________________________________
      4) Date Filed:
 
 

*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting to Be Held on June 10, 2011 
 


REGENERON PHARMACEUTICALS, INC.


 
      
 

       REGENERON PHARMACEUTICALS, INC.
       777 OLD SAW MILL RIVER ROAD
       TARRYTOWN, NY 10591-6707
 

 
Meeting Information
Meeting Type:         Annual Meeting
For holders as of:   April 13, 2011
Date:     June 10, 2011     Time:  10:30 AM EDT
Location:      Westchester Marriott Hotel
  670 White Plains Road
  Tarrytown, New York 10591
  For Meeting Directions go to:
  www.regeneron.com 
 
You are receiving this communication because you hold shares in the above named company.
 
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
 
We encourage you to access and review all of the important information contained in the proxy materials before voting.
See the reverse side of this notice to obtain proxy materials and voting instructions.


 
 

——  Before You Vote  ——
How to Access the Proxy Materials 
Proxy Materials Available to VIEW or RECEIVE:
1. Notice & Proxy Statement       2. Annual Report
How to View Online:
Have the information that is printed in the box marked by the arrow  è XXXX XXXX XXXX (located on the following page) and visit: www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET: www.proxyvote.com
2) BY TELEPHONE:    1-800-579-1639
3) BY E-MAIL*: sendmaterial@proxyvote.com
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow  è XXXX XXXX XXXX (located on the following page) in the subject line.
 
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 29, 2011 to facilitate timely delivery.
 

——  How To Vote  ——
Please Choose One of the Following Voting Methods 
 
Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
 
Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow  è XXXX XXXX XXXX available and follow the instructions.
 
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
 

 
 
 
  
 

 
Voting items
      
  The Board of Directors recommends you vote FOR the following:      
         
1.
  
Election of Directors
Nominees
  
 
    
01
  
Alfred G Gilman MD Ph.D
02    Joseph L. Goldstein M.D
03    Christine A. Poon
04    P. Roy Vagelos, M.D.
 
  
 
    
         
The Board of Directors recommends you vote FOR proposals 2, 3 and 4.
           
2.
  
Proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2011.
     
3.
  
Proposal to approve the Company's Second Amended and Restated 2000 Long-Term Incentive Plan.
     
4.
  
Proposal to approve, by non-binding advisory vote, executive compensation.
 
     
The Board of Directors recommends you vote 3 YEARS on the following proposal:
     
5.
  
Proposal to recommend, by non-binding advisory vote, the frequency of future advisory votes on executive compensation.
 
NOTE: In their discretion, the named proxies may vote on such other business as may properly come before the Annual Meeting or at any adjourned or postponed session thereof.